A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18681 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Yu-Hung Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Sciences, The University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Leukemia, Myelomonocytic, Chronic, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Cancer Research UK, Ministry of Health and Welfare, Ministry of Science and Technology, Taiwan.
Abstract (Originalsprache)
Leukaemic stem cell (LSC) gene expression has recently been linked to prognosis in patients with acute myeloid leukaemia (17‐gene LSC score, LSC‐17) and myelodysplastic syndromes. Although chronic myelomonocytic leukaemia (CMML) is regarded as a stem cell disorder, the clinical and biological impact of LSCs on CMML patients remains elusive. Making use of multiple independent validation cohorts, we here describe a concise three‐gene expression signature (LSC‐3, derived from the LSC‐17 score) as an independent and robust prognostic factor for leukaemia‐free and overall survival in CMML. We propose that LSC‐3 could be used to supplement existing risk stratification systems, to improve prognostic performance and guide management decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Sciences, The University of Manchester, Manchester, UK.
- Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
- Leukaemia Biology Laboratory, Cancer Research UK Manchester Institute, Manchester, UK.
- Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
- Haematology Department, Hospital Morales Meseguer, Murcia, Spain.
- Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Yu-Hung Wang, Chi-Yuan Yao, Chien-Chin Lin, Andres Jerez, Moritz Binder, Wen-Chien Chou, Daniel H Wiseman
Förderung
- Cancer Research UK
- Ministry of Health and Welfare
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Wang, Y. H., Yao, C. Y., Lin, C. C., Gurashi, K., Amaral, F. M. R., Bossenbroek, H., Jerez, A., Somervaille, T. C. P., Binder, M., Patnaik, M. M., Hou, H. A., Chou, W. C., Batta, K., Wiseman, D. H., & Tien, H. F. (2023). A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.18681
Vancouver
Wang YH, Yao CY, Lin CC, Gurashi K, Amaral FMR, Bossenbroek H, et al. A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. British Journal of Haematology. 2023. doi:10.1111/bjh.18681
BibTeX
@article{Wang2023,
author = {Wang, Yu-Hung and Yao, Chi-Yuan and Lin, Chien-Chin and Gurashi, Kristian and Amaral, Fabio M R and Bossenbroek, Hasse and Jerez, Andres and Somervaille, Tim C P and Binder, Moritz and Patnaik, Mrinal M and Hou, Hsin-An and Chou, Wen-Chien and Batta, Kiran and Wiseman, Daniel H and Tien, Hwei-Fang},
title = {A three‐gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18681}
}
EUVIMED